MedTrace Logo

Ultrasound Acute Chest Syndrome Sickle Cell Disease

NCT06880679 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-04-09

No results posted yet for this study

Summary

Feasibility and reliability of ultrasound in the inpatient hematology setting.

Conditions

Interventions

DEVICE

Point of Care Ultrasound

Point of Care Ultrasound during hospitalization

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Principal Investigators

  • Seethal Jacob, MD · Indiana University

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-08
Primary Completion
2026-06-30
Completion
2026-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06880679 on ClinicalTrials.gov